Efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: the phase 2b part of a randomized, placebo-controlled, phase 2/3 study

Hiroshi Mukae; Hiroshi Yotsuyanagi; Norio Ohmagari; Yohei Doi; Hiroki Sakaguchi; Takuhiro Sonoyama; Genki Ichihashi; Takao Sanaki; Keiko Baba; Yuko Tsuge; Takeki Uehara

bioRxiv (2022) - Comments
doi: 10.1101/2022.06.22.22276792

Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Hiroki Sakaguchi, Takuhiro Sonoyama, Genki Ichihashi, Takao Sanaki, Keiko Baba, Yuko Tsuge, Takeki Uehara